Citius Pharmaceuticals, Inc. (CTXR) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Citius Pharmaceuticals, Inc. (CTXR) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

CTXR Cash Flow Statement

Citius Pharmaceuticals, Inc. (CTXR) cash flow statement — 15-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-8.68M	-1.3M	-13.01M	-11.88M	-5.41M	-4.54M	-4.73M	-5.91M	-8.37M	-7.79M	-6.14M	-6.8M	-9.58M	-7.85M	-4.82M	-6.33M	-7.71M	-9.67M	-4.65M	-5.59M
Operating CF Margin %	-580.91%	-77.97%	-329.83%	-	-	-	-	-3791.98%	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-60.5%	71.36%	-175.27%	-100.94%	35.38%	41.7%	22.97%	13.05%	12.68%	0.85%	-27.17%	-7.39%	-24.25%	18.75%	-3.72%	-13.26%	-59.88%	-126.28%	51.37%	-66.51%
Net Income	-8.86M	-28.11M	-9.39M	-8.74M	-9.2M	-11.51M	-10.28M	-11.08M	-10.57M	-8.54M	-9.23M	-9.94M	-8.48M	-10.53M	-3.59M	-7.99M	-8.86M	-7.56M	-9.23M	-4.96M
Depreciation & Amortization	1.76M	40.66K	-16.48K	62.04K	41.37K	56.01K	54.84K	53.69K	52.85K	52.07K	51.01K	49.97K	49.02K	48.14K	47.19K	46.25K	45.35K	44.47K	43.61K	42.77K
Stock-Based Compensation	0	3.79M	4.28M	2.89M	2.72M	2.7M	2.52M	2.64M	3.06M	3.18M	3.06M	3.08M	1.17M	1.17M	1.2M	976.67K	1M	1.02M	904.6K	461.87K
Deferred Taxes	-107.35K	-231.21K	264.24K	264.24K	264.24K	264.24K	264.24K	144K	144K	144K	144K	144K	144K	144K	144K	576K	-1.11M	0	0	0
Other Non-Cash Items	933.74K	1.72M	749.54K	26.6K	0	0	0	1	109.95K	98.08K	76.15K	3.33M	918.07K	102K	923.25K	104.32K	1.11M	178K	95.88K	-166.56K
Working Capital Changes	-2.4M	21.49M	-8.89M	-6.38M	771.97K	3.95M	2.71M	2.33M	-1.16M	-2.61M	-233.46K	-126.19K	-2.47M	1.21M	-2.62M	-45.01K	102.57K	-3.35M	3.53M	-968.02K
Change in Receivables	392.82K	2.97M	-4.05M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	33.65K	-20.25K	-352.65K	-3.71M	-1.87M	-957.88K	-6.11M	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-1.42M	-1.57M	-2.67M	3.6M	725.81K	2M	2.44M	3.26M	-1.01M	22.26K	-280.08K	-152.33K	354.07K	1.19M	372.2K	-525.14K	-14.61K	-84.08K	512.11K	-77.57K
Cash from Investing	-2M	-600K	-4.4M	-5.75M	0	0	0	-5M	0	0	0	0	0	0	0	0	0	0	0	-40M
Capital Expenditures	-2M	-600K	0	-5.75M	0	0	0	-5M	-4	0	0	0	0	0	0	0	0	0	0	-40M
CapEx % of Revenue	133.89%	35.99%	-	-	-	-	-	3206.65%	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-4.4M	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	-40M
Cash from Financing	23.09M	-1.23M	20.88M	15.79M	11.47M	3.47M	2.57M	-3.75M	13.72M	0	0	-687	13.8M	31.27K	0	0	0	0	0	-120.47M
Debt Issued (Net)	9.63M	-1M	0	-1M	1.3M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	13.46M	-231.2K	20.88M	15.79M	10.47M	3.47M	2.57M	84.73K	13.72M	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	1M	-300K	0	0	-3.83M	0	0	0	-687	13.8M	31.27K	0	0	0	0	0	-31.04M
Net Change in Cash	12.42M	-3.13M	3.47M	-1.84M	6.06M	-1.07M	-2.15M	-14.66M	5.35M	-7.79M	-6.14M	-6.8M	4.22M	-7.82M	-4.82M	-6.33M	-7.71M	-9.67M	-4.65M	-45.59M
Free Cash Flow	-8.68M	-1.3M	-13.01M	-11.88M	-5.41M	-4.54M	-4.73M	-5.91M	-8.37M	-7.79M	-6.14M	-6.8M	-9.58M	-7.85M	-4.82M	-6.33M	-7.71M	-9.67M	-4.65M	-45.59M
FCF Margin %	-580.91%	-77.97%	-329.83%	-	-	-	-	-3791.98%	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-60.5%	71.36%	-175.27%	-100.94%	35.38%	41.7%	22.97%	13.05%	12.68%	0.85%	-27.17%	-7.39%	-24.25%	18.75%	-3.72%	86.11%	-59.65%	-126.28%	51.37%	-1257.77%
FCF per Share	-0.33	-0.06	-0.61	-0.66	-0.49	-0.39	-0.41	-0.51	-0.72	-0.73	-0.58	-0.64	-0.93	-0.81	-0.49	-0.65	-0.79	-0.99	-0.48	-4.67
FCF Conversion (FCF/Net Income)	0.98x	0.06x	1.58x	1.49x	0.62x	0.42x	0.48x	0.55x	0.79x	0.91x	0.66x	0.68x	1.13x	0.75x	1.34x	0.79x	0.88x	1.28x	0.50x	1.13x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0